leading semaglutide law office FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Ozempic Lawsuits: FDA Warnings, Legal

Wegovy (Oral) Wegovy (semaglutide) pill, a FDA-approved GLP-1 receptor agonist, taken once a day, to help regulate appetite and feelings of fullness

The FDA has expressed concern with direct-to-consumer marketing across the pharmaceutical industry and an intent to more aggressively enforce laws that require fair balance between a products risks and benefits

The SELECT trial published in the New England Journal of Medicine demonstrated a 20% relative risk reduction in major adverse cardiovascular events (MACE) with semaglutide 2.4mg weekly compared to placebo in patients with established cardiovascular disease

Exercise programming Resistance training is non-negotiable for optimal body composition during weight loss

Future studies may apply a Mendelian randomization approach to elucidate the association between functional IGF-1R polymorphisms and BrCa risk